Junyan Yu
Changzhi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Prognostic significance of tumoral Siglec-15 expression in solid tumors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: June 10, 2026
Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases.
Journal: Frontiers in medicine
Published: April 09, 2026
Association between infertility and thyroid cancer risk: a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: February 19, 2026
Development, characterization, and evaluation of the therapeutic efficacy of PEGylated-nanoliposomal artesunate in mice bearing non-small cell lung carcinoma.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 05, 2026
Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors.
Journal: Drug design, development and therapy
Published: June 12, 2025
Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: March 13, 2024
Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: a multicenter, randomized, double-blind, placebo-controlled, phase II study.
Journal: Therapeutic advances in medical oncology
Published: January 10, 2024
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.
Journal: Cancer communications (London, England)
Published: October 31, 2023
Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study.
Journal: Cell reports. Medicine
Published: May 10, 2023
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202).
Journal: Journal of gastrointestinal oncology
Published: July 05, 2022
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 09, 2021
Last Updated: 09/26/2026